Mechanisms of Oxidative Glutamate Toxicity: The Glutamate/Cystine Antiporter System xc¯ as a Neuroprotective Drug Target

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|9|3|373-382

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.9, Iss.3, 2010-07, pp. : 373-382

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Response to Mousavizadeh et al.: Oxidative toxicity and glutamate excitotoxicity in multiple sclerosis

By Neuhaus O.   Kieseier B.C.   Archelos J.J.   Hartung H.-P.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 11, 2003-11 ,pp. : 564-565

Elsevier

Access to resources Recommend Favorite

Imaging the Glutamate System in Humans: Relevance to Drug Discovery for Schizophrenia

By  

Current Pharmaceutical Design, Vol. 15, Iss. 22, 2009-08 ,pp. : 2594-2602

Bentham Science Publishers

Access to resources Recommend Favorite

The neuroprotective agent MS-153 stimulates glutamate uptake

By Shimada F.   Shiga Y.   Morikawa M.   Kawazura H.   Morikawa O.   Matsuoka T.   Nishizaki T.   Saito N.  

European Journal of Pharmacology, Vol. 386, Iss. 2, 1999-12 ,pp. : 263-270

Elsevier

Access to resources Recommend Favorite

Metabotropic Glutamate Receptors as Drug Targets

By  

Current Drug Targets, Vol. 8, Iss. 5, 2007-05 ,pp. : 651-681

Bentham Science Publishers

Access to resources Recommend Favorite

Glutamate signalling in bone: a therapeutic target for osteoporosis?

By Genever P.G.   Skerry T.M.  

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 2, 2000-04 ,pp. : 207-218

Informa Healthcare

Access to resources Recommend Favorite